<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04756492</url>
  </required_header>
  <id_info>
    <org_study_id>Soh-Med-21-02-06</org_study_id>
    <nct_id>NCT04756492</nct_id>
  </id_info>
  <brief_title>Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital</brief_title>
  <official_title>Prognostic Factors for Treatment Responses in Patients With Active Lupus Nephritis at Sohag University Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sohag University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sohag University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Systemic lupus erythematosus (SLE) is an autoimmune disease which may give rise to multiple&#xD;
      organ involvement because of immune complex deposits. Lupus nephritis (LN) is one of the&#xD;
      severe manifestations of systemic lupus erythematous (SLE) and a common cause for end-stage&#xD;
      renal disease, significantly affecting the survival of SLE patients Immunosuppressive&#xD;
      treatment is the major therapy for active LN. Generally, at least six months are needed to&#xD;
      assess treatment responses Failure to respond to immunosuppressive therapy can lead to a&#xD;
      worsening of renal function&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will be prospectively analyzing the clinical data of LN patients who received&#xD;
      standard immunosuppressive therapy and were regularly followed up at our center for more than&#xD;
      six months. These patients will not change treatment regimen during the six months.&#xD;
&#xD;
      As remission is an independent predictor of good long term prognosis in lupus nephritis. We&#xD;
      aim to examine the predictors of sustained complete renal remission in patients with lupus&#xD;
      nephritis at Sohag University Hospital and to analyze data of lupus nephritis patients to&#xD;
      find parameters that can predict remission and improve outcome of our cases&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">February 15, 2021</start_date>
  <completion_date type="Anticipated">February 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">February 15, 2023</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>complete renal response</measure>
    <time_frame>6 months</time_frame>
    <description>Alb _35 g/l, UPCR&lt;0.3 g/g, a normal range of sCr or at a level increasing no more than 15% from baseline and without lupus flares.</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>We Aim to Examine the Predictors of Sustained Complete Renal Remission in Patients With Lupus Nephritis at Sohag University Hospital</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>sandimmun</intervention_name>
    <description>follow up for treatment response</description>
    <other_name>indoxan</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        o Patients diagnosed with LN at Sohag University Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  o Patients diagnosed with LN at Sohag University Hospital&#xD;
&#xD;
               -  Patients in regular follow-up for more than six months after immunosuppressive&#xD;
                  therapy&#xD;
&#xD;
               -  Baseline urinary protein/creatinine ratio (UPCR) more than 1 g/g&#xD;
&#xD;
               -  Baseline C3 less than 55 mg/ dl&#xD;
&#xD;
               -  No change in immunosuppressive therapy within six months&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  o Patients with incomplete pathological data and the number of glomeruli being &lt;10 per&#xD;
             biopsy specimen&#xD;
&#xD;
               -  Age &lt;14 years old End-stage renal disease (ESRD) status on admission (sustained&#xD;
                  estimated glomerular filtration rate (eGFR) &lt;15 ml/min per 1.73m2)&#xD;
&#xD;
               -  Patients with advanced comorbid conditions like advanced liver cirrhosis or heart&#xD;
                  failure or malignancy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Sohag University</name>
      <address>
        <city>Sohag</city>
        <zip>088</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>February 14, 2021</study_first_submitted>
  <study_first_submitted_qc>February 14, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 16, 2021</study_first_posted>
  <last_update_submitted>February 14, 2021</last_update_submitted>
  <last_update_submitted_qc>February 14, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sohag University</investigator_affiliation>
    <investigator_full_name>Ahmed Mahmoud Helmy</investigator_full_name>
    <investigator_title>assistant lecture</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nephritis</mesh_term>
    <mesh_term>Lupus Nephritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclosporine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>sharing final results only</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

